Description
Overview
Polymalt-F Tablets is a water soluble, iron oxide, macromolecular complex of poly nuclear iron (III) hydroxide and partially hydrolysed dextrin ( Polymaltose).It is used in treatment of latent iron deficiency and iron deficiency anaemia.
Indications
Polymalt-F Tablets is primarily indicated in conditions like Iron deficiency, Iron deficiency anaemia, Macrocytic anaemia, and can also be given in adjunctive therapy as an alternative drug of choice in Anoxic Seizures, Cough.
Contraindication
Polymalt-F Tablets is contraindicated in conditions like Hemochromatosis,Haemolytic anaemia, Hemoglobinopathy,Inflammatory bowel disease, Blood transfusion,Haemochr omatosis, Haemosiderosis, Sidero-achrestic anaemia,Thalassemia, Hypersensitivity to any component of product.
Side Effects
The severe or irreversible adverse effects of Polymalt-F Tablets, which give rise to further complications include Convulsions, Hepatic failure.Polymalt-F Tablets produces potentially life-threatening effects which include Anaphylactoid reactions, circulatory collapse, Circulatory collapse. which are responsible for the discontinuation of Polymalt-F Tablets therapy. The signs and symptoms that are produced after the acute overdosage of Polymalt-F Tablets include Vomiting, Tachycardia, Diarrhea, Convulsions, Coma, Drowsiness, Metabolic acidosis, Hypoglycemia, Abdominal pain, Epigastric pain, Hyperventilation, Restlessness, GI hemorrhage, Cyanosis, Hypotensive collapse, Hemorrhagic gastroenteritis, Hepatic failure, coaggulation disorder, Haemochromatosis, Endocrine dysfunction. The symptomatic adverse reactions produced by Polymalt-F Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Diarrhea, Constipation, Sweating, Epigastric discomfort, Flushing, Taste disturbance, Nausea and vomiting, Heart burn, GI irritation, Sense of repletion, dizziness, Black colour Faeces, Tooth discoloration, Local Inflamation, Joint & muscle pain.
Reviews
There are no reviews yet.